Precision Brain Analytics for Clinicians
Home > LucerumCarto
Precision Neuroanalytics for Clinicians
LucerumCarto addresses the challenge clinicians face in extracting actionable insights from EEG and neuroimaging, creating a robust foundation for personalized neuropsychiatric and performance brain assessments, with advanced tools for precision neuromodulation. It integrates advanced EEG tomography and network connectomics to support diagnostics, treatment planning, and neuromodulation strategies for neurology, psychiatry, pain, addiction, and brain performance.
- User-friendly portal built for clinicians
- Secure patient database
- Advanced qEEG / neuroimaging analytics
- Connectomics biomarkers
- Neurotransmitter predictions
- Multivariate models for clinical outcomes and predictions
- qEEG TMS guidance and qEEG-neuromodulation
Enhanced Diagnostic with qEEG Tomography
Unlocking new potential for personalized medicine with high-resolution subject-specific brain analysis.
Personalized EEG/MEG tomography integrates functional source localization with the subject’s unique anatomical structure derived from MRI, providing precise, individualized functional brain maps to support diagnosis, treatment planning, and therapeutic interventions.
qEEG-Based Neurofeedback: Enhancing Brain Performance
LucerumCarto enables the next generation of z-scored swLORETA qEEG-based neurofeedback, a non-invasive, personalized approach to improving brain function by training individuals to regulate their own brainwave activity.
Precision qEEG-Guided TMS and Neuronavigation
Transcranial Magnetic Stimulation (TMS) is a non-invasive neuromodulation technique that uses magnetic fields to stimulate targeted areas of the brain. TMS is FDA-approved for treating conditions such as depression, with emerging research supporting its use in anxiety, chronic pain, and neurological rehabilitation. Recent advancements in neuroimaging have enabled the development of personalized TMS protocols that target specific neural circuits implicated in psychiatric disorders.
By precisely mapping the subject’s dysregulation in functional connectivity patterns with normative qEEG tomography, LucerumCarto identifies optimal stimulation sites and support neuronavigation.
- Interactive dysregulation maps
- Alignment of qEEG maps with SAINT fMRI results
- Precision E-Field modeling and coil placement
- Longitudinal tracking
Lucerum Inc. sponsors TMS research. Contact us for opportunities and incentives!
